Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

A new study finds the growing number of threats at work prompted 45 percent of healthcare employees to say they're likely to ...

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

The market expects Moderna (MRNA) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is ...

Biotechnology company Veracyte (VCYT) is set to replace Triumph Group (TGI) in the S&P SmallCap 600 index prior to the market open on Tuesday, July 29.

BioMarin Pharmaceuticals is one of many biotech companies that’s laid off workers over the past two years. Its office in ...

The newest master's degree offered by UT Dallas is among the first of its kind in Texas and focuses on AI applications within ...

Shares of Chinese biotechnology company Nanjing Leads Biolabs surged in their Hong Kong debut after overwhelming demand from investors. Shares surged as much as 127% to 79.60 Hong Kong dollars, ...

This week on "The Readout LOUD" podcast, a mother whose son has Duchenne muscular dystrophy shares her perspective on Sarepta ...

The trial will include patients with non-small cell lung, colorectal, head and neck, and cutaneous cancers with EGFR amplification.